TY - JOUR
T1 - Vaccine equity
T2 - Past, present, and future
AU - van der Graaf, Rieke
AU - Browne, Joyce L.
AU - Baidjoe, Amrish Y.
N1 - Funding Information:
The authors would like to express their appreciation to the suggestions of Dr. Judith van de Kamp about the historical context on health inequities and would like to thank all global actors who continue to tirelessly address matters of unequal access to health both in speech as well in practice. Conceptualization, R.v.d.G. J.L.B. A.Y.B.; Writing – original draft, R.v.d.G.; Writing – original figure, J.L.B.; Writing – Review & Editing, R.v.d.G. J.L.B. and A.Y.B. R.v.d.G. J.L.B. and A.Y.B. declare no competing interests.
Publisher Copyright:
© 2022 The Author(s)
PY - 2022/3/15
Y1 - 2022/3/15
N2 - The term “vaccine equity” primarily points to the enormous imbalance in global COVID-19 vaccine distribution. Vaccine equity should adopt a normative approach toward “health equity,” and various stakeholders across the vaccine life cycle must practice it. The momentum gathered during this pandemic must be used to correct these structural imbalances.
AB - The term “vaccine equity” primarily points to the enormous imbalance in global COVID-19 vaccine distribution. Vaccine equity should adopt a normative approach toward “health equity,” and various stakeholders across the vaccine life cycle must practice it. The momentum gathered during this pandemic must be used to correct these structural imbalances.
KW - COVID-19 Vaccines/therapeutic use
KW - COVID-19/epidemiology
KW - Health Equity
KW - Humans
KW - Pandemics/prevention & control
KW - Vaccines/therapeutic use
UR - http://www.scopus.com/inward/record.url?scp=85126298530&partnerID=8YFLogxK
U2 - 10.1016/j.xcrm.2022.100551
DO - 10.1016/j.xcrm.2022.100551
M3 - Article
C2 - 35474741
AN - SCOPUS:85126298530
SN - 2666-3791
VL - 3
SP - 1
EP - 4
JO - Cell Reports Medicine
JF - Cell Reports Medicine
IS - 3
M1 - 100551
ER -